TY - JOUR
T1 - Postoperative Hemorrhagic Occlusive Retinal Vasculitis
T2 - Expanding the Clinical Spectrum and Possible Association with Vancomycin
AU - Witkin, Andre J.
AU - Shah, Anjali R.
AU - Engstrom, Robert E.
AU - Kron-Gray, Michelle M.
AU - Baumal, Caroline R.
AU - Johnson, Mark W.
AU - Witkin, Deborah I.
AU - Leung, John
AU - Albini, Thomas A
AU - Moshfeghi, Andrew A.
AU - Batlle, Ivan R.
AU - Sobrin, Lucia
AU - Eliott, Dean
PY - 2015/7/1
Y1 - 2015/7/1
N2 - Purpose To describe a syndrome of hemorrhagic occlusive retinal vasculitis (HORV) that developed after seemingly uncomplicated cataract surgery. Design Retrospective case series. Subjects Eleven eyes of 6 patients from 6 different institutions. Methods Cases were identified after discussion among retina specialists. The findings on presentation, clinical course, and outcome of a series of 7 eyes of 4 patients were compared with a previous report of 4 eyes of 2 patients, and data from both series were combined for a comprehensive analysis. Main Outcome Measures Historical data, examination findings, imaging results, systemic evaluation findings, treatment regimens, and visual outcomes. Results Eleven eyes of 6 patients underwent otherwise uncomplicated cataract surgery, receiving viscoelastic and prophylactic intracameral vancomycin during the procedure. Despite good initial vision on postoperative day 1, between 1 to 14 days after surgery, all eyes demonstrated painless vision loss resulting from HORV. Extensive ocular and systemic evaluations were unrevealing in all patients. All patients were treated with aggressive systemic and topical corticosteroids. Additional treatments included systemic antiviral medication in 4 patients, intravitreal antibiotics in 4 eyes, and pars plana vitrectomy in 4 eyes. Skin testing for vancomycin sensitivity showed negative results in 3 patients and was not performed in the others. Neovascular glaucoma developed in 7 eyes, and all eyes received intravitreal anti-vascular endothelial growth factor (VEGF) injection, panretinal photocoagulation, or both for retinal ischemia. Final visual acuity was less than 20/100 in 8 of 11 eyes. Conclusions Postoperative HORV is an exceedingly rare and potentially devastating condition that can occur after otherwise uncomplicated cataract surgery. Although the precise cause remains unknown, this disease may represent a delayed immune reaction similar to vancomycin-induced leukocytoclastic vasculitis. Despite treatment with high-dose corticosteroids, antiviral medication, and early vitrectomy in many patients, visual outcomes typically were poor in this series. Early intervention with intravitreal anti-VEGF medication and panretinal photocoagulation may help to prevent additional vision loss resulting from neovascular glaucoma.
AB - Purpose To describe a syndrome of hemorrhagic occlusive retinal vasculitis (HORV) that developed after seemingly uncomplicated cataract surgery. Design Retrospective case series. Subjects Eleven eyes of 6 patients from 6 different institutions. Methods Cases were identified after discussion among retina specialists. The findings on presentation, clinical course, and outcome of a series of 7 eyes of 4 patients were compared with a previous report of 4 eyes of 2 patients, and data from both series were combined for a comprehensive analysis. Main Outcome Measures Historical data, examination findings, imaging results, systemic evaluation findings, treatment regimens, and visual outcomes. Results Eleven eyes of 6 patients underwent otherwise uncomplicated cataract surgery, receiving viscoelastic and prophylactic intracameral vancomycin during the procedure. Despite good initial vision on postoperative day 1, between 1 to 14 days after surgery, all eyes demonstrated painless vision loss resulting from HORV. Extensive ocular and systemic evaluations were unrevealing in all patients. All patients were treated with aggressive systemic and topical corticosteroids. Additional treatments included systemic antiviral medication in 4 patients, intravitreal antibiotics in 4 eyes, and pars plana vitrectomy in 4 eyes. Skin testing for vancomycin sensitivity showed negative results in 3 patients and was not performed in the others. Neovascular glaucoma developed in 7 eyes, and all eyes received intravitreal anti-vascular endothelial growth factor (VEGF) injection, panretinal photocoagulation, or both for retinal ischemia. Final visual acuity was less than 20/100 in 8 of 11 eyes. Conclusions Postoperative HORV is an exceedingly rare and potentially devastating condition that can occur after otherwise uncomplicated cataract surgery. Although the precise cause remains unknown, this disease may represent a delayed immune reaction similar to vancomycin-induced leukocytoclastic vasculitis. Despite treatment with high-dose corticosteroids, antiviral medication, and early vitrectomy in many patients, visual outcomes typically were poor in this series. Early intervention with intravitreal anti-VEGF medication and panretinal photocoagulation may help to prevent additional vision loss resulting from neovascular glaucoma.
UR - http://www.scopus.com/inward/record.url?scp=84937731632&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84937731632&partnerID=8YFLogxK
U2 - 10.1016/j.ophtha.2015.03.016
DO - 10.1016/j.ophtha.2015.03.016
M3 - Article
C2 - 25886796
AN - SCOPUS:84937731632
VL - 122
SP - 1438
EP - 1451
JO - Ophthalmology
JF - Ophthalmology
SN - 0161-6420
IS - 7
M1 - 8595
ER -